Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 15
- Q3 2025, +5 vs. previous quarter
- 13F value
- $2.94M
- Reported value at the end of Q3 2025
- Superinvestors holding
- 0
- At the end of Q3 2025
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2024
- $10.2M
- +97.8% year over year
- Net income, FY2024
- -$5.35M
- No comparable prior period
- Free cash flow, FY2024
- –
- No comparable prior period
- Revenue, Q3 FY2025
- $4.28M
- +61.4% year over year
Revenue flow, FY2024
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2024: $5.35M (52.2% of revenue).
Short interest
See short dataFrom FINRA, settlement date Dec 15, 2025.
- Short interest
- 10.9K
- Shares sold short
- Change
- +3.92K
- +56.2% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding EVOK, Q3 2025
Go to the superinvestors tabNo superinvestor reported holding EVOK at the end of Q3 2025.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Evoke Pharma Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 (view filing) | Nov 6 | 1 day | Klein Roger M.10% Owner | SSale | −9.00K | $10.66 | −$95.9K | −6.7%125.0K after | 2 lots |
| Jan 30, 2025 (view filing)6:39 PM ET | Jan 28 | 2 days | Nantahala Capital Management, LLC and 2 others10% Owner | SSale | −41 | $4.39 | −$179.87 | 0.0%148.2K after |
Top 10 13F holders, Q3 2025
See all 15 holdersThe largest institutional positions in Evoke Pharma Inc at the end of Q3 2025; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 159,358 | $792.0K | 0.00% | +159,294+248,896.9% | Added |
| Nantahala Capital Management, LLC | 148,153 | $736.3K | 0.05% | 00.0% | Unchanged |
| Bleichroeder LP | 146,395 | $727.6K | 0.14% | +77,645+112.9% | Added |
| National Wealth Management Group, LLC | 80,130 | $398.2K | 0.15% | +80,130 | New |
| DRW Securities, LLC | 23,742 | $118.0K | 0.01% | +23,742 | New |
| Vanguard Group Inc | 18,759 | $93.2K | 0.00% | +18,759 | New |
| Two Sigma Securities, LLC | 10,437 | $51.9K | 0.01% | +10,437 | New |
| Advisor Group Holdings, Inc. | 3,010 | $16.4K | 0.00% | +3,010 | New |
| Northwestern Mutual Wealth Management Co | 272 | $1.35K | 0.00% | +272 | New |
| Royal Bank of Canada | 190 | $1.00K | 0.00% | +190 | New |
Holders of 5% or more of EVOK
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Evoke Pharma Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Klein Roger M. | 13D | 10.50%163.0K shares | New | Nov 12, 20251 filing | Nov 12, 2025 | SEC |
| Bleichroeder LP | 13G/A | 9.99%158.1K shares | 0.00 ppfrom 9.99% | Mar 11, 20243 filings | Mar 24, 2025 | SEC |